Myeloproliferative neoplasm with basophilia and abnormality of platelet-derived growth factor receptor a translocation: a case report
Open Access
- 31 March 2022
- journal article
- letter
- Published by Springer Nature in Blood Research
- Vol. 57 (1) , 69-74
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Role of platelet-derived growth factors in physiology and medicineGenes & Development, 2008
- Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusionHaematologica, 2008
- Two novel imatinib‐responsive PDGFRA fusion genes in chronic eosinophilic leukaemiaBritish Journal of Haematology, 2007
- Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA–positive chronic eosinophilic leukemiaBlood, 2007
- Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2‐PDGFRA fusion geneGenes, Chromosomes and Cancer, 2006
- Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophiliaLeukemia, 2006
- Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogeneticsLeukemia, 2005
- Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndromeBlood, 2004
- PDGFRA Activating Mutations in Gastrointestinal Stromal TumorsScience, 2003
- Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocationCell, 1994